| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028298277 |
| P356 | DOI | 10.1023/A:1006267902186 |
| P698 | PubMed publication ID | 10448875 |
| P2093 | author name string | Corona R | |
| Lemke S | |||
| Reidenberg MM | |||
| Coyle T | |||
| Winfield J | |||
| Lorenzo B | |||
| Bushunow P | |||
| Himpler B | |||
| Wasenko J | |||
| P2860 | cites work | Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 |
| The effect of gossypol and 6-aminonicotinamide on tumor cell metabolism: a 31P-magnetic resonance spectroscopic study | Q30859728 | ||
| Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123 | Q34559975 | ||
| Phosphorylation of Pyruvate Kinase and Glycolytic Metabolism in Three Human Glioma Cell Lines | Q34711580 | ||
| Oral gossypol in the treatment of metastatic adrenal cancer | Q34731011 | ||
| Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells | Q36422384 | ||
| Enzymes, isozymes, and enzyme variants in the diagnosis of cancer. A short review | Q39816088 | ||
| Gossypol: A Potential Antifertility Agent for Males | Q40179318 | ||
| Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study | Q40755871 | ||
| In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines | Q41504448 | ||
| Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers | Q41701517 | ||
| Gossypol-induced apoptotic DNA fragmentation correlates with inhibited protein kinase C activity in spermatocytes | Q42521398 | ||
| Lactate dehydrogenase isoenzymes in the diagnosis of human benign and malignant brain tumors. | Q44188458 | ||
| Lactate dehydrogenase isoenzymes and proteins in human gliomas | Q44465984 | ||
| Developing gossypol derivatives with enhanced antitumor activity | Q44949666 | ||
| Sites of action of gossypol studied by autoradiography and enzyme histochemistry | Q48102045 | ||
| Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults | Q48303492 | ||
| Supernumerary lactate dehydrogenase isozymes in human gliomas | Q48744695 | ||
| Chemotherapy of high-grade gliomas: beginning of a new era or the end of the old? | Q48836330 | ||
| Lactate dehydrogenase isoenzymes in tumours of the nervous system | Q48873616 | ||
| Differences in serum potassium concentrations in normal men in different geographic locations. | Q50673219 | ||
| A preliminary clinical study of gossypol in advanced human cancer | Q67552722 | ||
| Interaction of gossypol with amino acids and peptides as a model of enzyme inhibition | Q69407187 | ||
| Pharmacokinetics of (+/-)-, (+)-, and (-)-gossypol in humans and dogs | Q69510501 | ||
| Gossypol in the treatment of endometriosis and uterine myoma | Q70369867 | ||
| Lactate dehydrogenase-X: an isozyme particularly sensitive to gossypol inhibition | Q70428390 | ||
| [Effect of gossypol acetic acid on the uterus and ovary] | Q70663032 | ||
| Serum potassium: values in normal men in Shanghai vs those in men from Shanghai living abroad | Q72786243 | ||
| Gossypol arrests human benign prostatic hyperplastic cell growth at G0/G1 phase of the cell cycle | Q73311010 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 79-86 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Gossypol treatment of recurrent adult malignant gliomas | |
| P478 | volume | 43 |
| Q35234305 | A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer. |
| Q35980997 | A validated HPLC assay for the determination of R-(-)-gossypol in human plasma and its application in clinical pharmacokinetic studies |
| Q37406947 | AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis |
| Q39997013 | Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol. |
| Q45230466 | Antiproliferative plant and synthetic polyphenolics are specific inhibitors of vertebrate inositol-1,4,5-trisphosphate 3-kinases and inositol polyphosphate multikinase |
| Q64101518 | Arsenic Trioxide and (-)-Gossypol Synergistically Target Glioma Stem-Like Cells via Inhibition of Hedgehog and Notch Signaling |
| Q60935363 | Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma |
| Q26823996 | Bcl-2 antagonists: a proof of concept for CLL therapy |
| Q36483749 | Broad targeting of resistance to apoptosis in cancer. |
| Q44273742 | Determination of the absolute configuration and solution conformation of gossypol by vibrational circular dichroism |
| Q44926501 | Differential growth inhibition and induction of apoptosis by gossypol between HCT116 and HCT116/Bax(-/-) colorectal cancer cells |
| Q55456917 | Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model. |
| Q33682689 | Emerging Bcl-2 inhibitors for the treatment of cancer |
| Q35929218 | Evaluation of anticancer properties of a decoction containing Adenanthera pavonina L. and Thespesia populnea L |
| Q37124747 | Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents |
| Q37625020 | Gossypol--a polyphenolic compound from cotton plant |
| Q73081899 | Gossypol-induced DNA breaks in rat lymphocytes are secondary to cytotoxicity |
| Q35387996 | Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo |
| Q34687012 | Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models. |
| Q36300043 | Investigations on gossypol: past and present developments |
| Q92542085 | LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition |
| Q91649922 | Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy |
| Q92410138 | Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment |
| Q58605915 | Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy |
| Q37168749 | Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds |
| Q73555967 | Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells |
| Q34771514 | Non-cytotoxic therapies for malignant gliomas |
| Q36960751 | Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy. |
| Q92344226 | Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox |
| Q43711065 | Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. |
| Q37466253 | Programmed cell death pathways and current antitumor targets |
| Q47222664 | Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres |
| Q60520379 | SEPARATION OF MULTI-MILLIGRAM QUANTITIES OF GOSSYPOL ENANTIOMERS ON POLYSACCHARIDE-BASED STATIONARY PHASES |
| Q35099238 | Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy |
| Q37761935 | Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics |
| Q38677019 | Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma |
| Q83158104 | Targeting mitochondria for cancer therapy |
| Q38565718 | The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor |
| Q26851645 | The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond |
| Q38205134 | The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline |
Search more.